In the arena of drug-resistant neoplasms, scholarly research suggests that Leo can depress the expression of resistance-associated proteins present in drug-resistant lung adenocarcinoma cells and inhibit cellular proliferation by stifling STAT3 activation, thus combating drug resistance. This evidence concerns the gene STAT3 and neoplasm.